stella
beta
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL. — Stella
Recruiting
Back to Peripheral T Cell Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shanghai General Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov